Clinical Pharmacology final Flashcards
An example of polypragmasy (NOTE: MULTIPLE CHOICE):
A. simultaneous use of at least 5 drugs
B. improvement of the therapeutic effect through the use of an appropriate combination of drugs adapted to the patient’s health condition and its comorbidities
C. patient takes at least one drug for which there is no indication
D. use of more drugs than is clinically indicated
E. simulates use of up to 4 drugs
A. simultaneous use of at least 5 drugs
B. improvement of the therapeutic effect through the use of an appropriate combination of drugs adapted to the patient’s health condition and its comorbidities
Individuals can be classified as extensive Imetabolizers, poor metabolizers or ultrarapid metabolizers. Both codeing
and nortripty line are metabolized by CYP2D6. Codeine is metabolized into an active agent (morphine), conversely,
nortriptyline is the active therapeutic agent and is metabolized to an inactive form. Subjects who are poor
metabolizes based upon CYP2D6 genotype:
A. may require increased dosing both of codeine and nortriptyline for a given therapeutic effect
B. may require increased dosing of codeine for a given therapeutic effect, while dosage of nortripty line should
be reduced as there is concern of side effects
C. may require increased dosing of nortriptyline for a given therapeutic effect, while dosage of codeine should
be reduced as there is concern of side effects
D. dosage both of codeine and nortripty line should be reduced as there is concern of side effects
E. no answer is correct
B. may require increased dosing of codeine for a given therapeutic effect, while dosage of nortripty line should
be reduced as there is concern of side effects
Therapies A, B, C iD have different cost and effectiveness. Indicate therapy which dominates:
A. cost: 15 000 PLN, effectiveness: 25 B. cost: 39 000 PLN, effectiveness: 28 C. cost: 41 000 PLN, effectiveness: 22 D. cost: 40 000 PLN, effectiveness: 19 E. cost: 42 000 PLN, effectiveness: 23
A. cost: 15 000 PLN, effectiveness: 25
A patient with diagnosed persistent atrial fibrillation takes warfarin 5 mg once daily. What effect on INR will have
the addition of neomycine and what mechanism of interaction is most likely?
A. INR increase, pharmacodynamic antagonism
B. INR decrease, pharmacodynamic antagonism
C. INR increase, pharmacodynamic synergism
D. INR decrease, pharmacodynamic synergism
E. INR increae, displacement from plasma protein bindings
C. INR increase, pharmacodynamic synergism
TPMT is responsible for the metabolism of:
A. methotrexate B. azathioprine C. tacrolimus D. all answers are correct E. leflunomide
B. azathioprine
–> (Thiopurine methyltransferase metabolises thiopurines)
What is „trough” drug concentration?
A. the lowest concentration reached by a drug before the next dose is administered, as determined ed by therapeutic drug monitoring
B. toxic blood concentration
C. concentration in the steady-state
D. lethal drug concentration
E. the highest concentration in the therapeutic range
A. the lowest concentration reached by a drug before the next dose is administered, as determined ed by therapeutic drug monitoring
Gene responsible for prolonged respiratory muscular paralysis after receiving standard dose of succinyl cholinesterase
A. NAT2 B. TPMT C. ABCB1 D. BCHE E. YP2D6
D. BCHE
A patient with diagnosed persistent atrial fibrillation takes warfarin 5 mg once daily. What effect on INR will
have the addition of cimetidine and what mechanism of interaction is most likely?
A. INR increase, pharmacodynamic synergism
B. INR decrease, pharmacodynamic antagonism
C. INR increase, displacement from plasma protein bindings
D. INR decrease, induction of CYP450 activity
E. INR increase, inhibition of CYP450 activity
E. INR increase, inhibition of CYP450 activity
What type of adverse drug reactions is adrenal suppression with corticosteroids? A. A B. B C. C D. D E. E
A. A
16.In cost-utility analysis QALY is a common measure of outcome. Based on cost utility ratios, ie.cost/QALY that
are given for 3 therapies, choose the most favourable therapy:
A. implementation of an artificial cardiac pacemaker in a patient with bradyarrhytmia-100 000 PLN/QALY
B. use of infliximab in treatment of severe flare of Crohn’s disease -250 000/QALY
C. specialistic program of neonatology care 50 000 PLN/QALY
D. breast cancer screening 120 000 PLN/QALY
E. mentioned therapies concern different populations and therefore cannot be compared
C. specialistic program of neonatology care 50 000 PLN/QALY
Drugs may differ in extent of plasma protein binding (EPB). The dosage of which drug should be reduced the most
in nephrotic syndrome?
A. phenobarbital, EPB = 4% B. digoxin, EPB = 20% C. methotrexate, EPB = 50% D. chlorpropamide, EPB = 80% E. warfarin, EPB = 99%
E. warfarin, EPB = 99%
Digoxin is bound to plasma proteins in 20%. In a patient with liver failure and associating hypoalbuminemia there
is the reduction of protein binding by 10%. How much would the unbound fraction of the drug increase in this
case?
A. by 10% B. by 12.5% C. by 50% D. by 75% E. by 80%
A. by 10%
Probenecid is a week acid, while diazepam is a week base. In which disease state the absorption of probenecid
would increase?
A. Zollinger-Ellisona syndrome B. Addison-Biermer disease C. state after gastrectomy D. chronic use of proton pump inhibitors E. absorption of weak acids does not depend on Gl pH
A. Zollinger-Ellisona syndrome
The standard dose of sertraline is 50 mg. Creatinine clearance in the patient was assessed to be 20 ml/min. What is
the required dose of sertraline in this patient, assuming that normal creatinine clearance is 100 ml/min.
A. 10 mg B. 20 mg C. 40 mg D. 50 mg E. 100 mg
A. 10 mg
General indicative therapeutic guidelines for changing dosing of drugs in elderly patients include (NOTE
MULTIPLE CHOICE):
A. A. over 85 years of age - drug doses should be reduced by 30%
B. B. from 76 to 85 years of age - drug doses should be reduced by 20%
C. C. from 65 to 75 cars of age - drug doses should be reduced by 30%
D. D. from 70 to 82 years - doses should be increased by 10%
E. E. from 60 to 70 years of age - doses should be increased by 5%
A. A. over 85 years of age - drug doses should be reduced by 30%
B. B. from 76 to 85 years of age - drug doses should be reduced by 20%
Indicate the true statement regarding the treatment of affective disorders and depression in pregnancy:
- if mother’s current illess is severe and threatening to her and the baby to the point that the risk of not taking treatment outweighs the risk of potential foetal harm
- in the first trimester of pregnancy the treatment of choice for depression is psychotherapy and phototherapy together with attempts to discontinue antidepressants, if any
- the pharmacotherapy of schizophrenia during pregnancy, if necessary, should consist of drugs well known in polypharmacy in order to increase the chance of obtaining synergistic optimal effect and choosing the safest during pregnancy preparations of depot form administered intramuscularly
- In the first trimester of pregnancy, sertaline or fluoxetine should be given in the lowest doses if absolutely necessary in depressed patients
- the drugs of choice for the treatment of psychotic disorders in pregnant patients are A typical neuroleptics such as triflucoperidol or zuclopenthixol given together with lithium carbonate and valproate as mood stabilisers to maintain remission of schizophrenia symptoms
A. 2,3,4 B.2,5 C. 1,3,5 D. 1,2,4 E. 3,4
D. 1,2,4
Indicate the correct combination of the product in question being marketed and the institution responsible for monitoring its safety on the market (multiple choice)
A. Medical devices - Department of Therapeutic Information of the Ministry of Health
B. Medicinal products - National Institute of Medicines in Warsaw
C. Dietary supplements - Chief Sanitary Inspector
D. Vaccines - Institute of Biotechnology of Serums and Vaccines
E. Dermocosmetics - the Institute of Occupational Medicine named after prof. dr. Jerzy Nofer in Łódź
B. Medicinal products - National Institute of Medicines in Warsaw
C. Dietary supplements - Chief Sanitary Inspector
Indicate the correct statements (NOTE: MULTIPLE CHOICE):
A. Detailed, currently valid information on the individualization of the dosage of the drug in a patient with renal insufficiency can be found in hospital prescriptions and the clinical trial brochure.
B. Formats CKD-EPI and Childe-Pugh scale allow estimation of creatinine clearance and constant rate of drug elimination in patients with acute kidney injury
C. The RUCAM classification and the R-value are used to assess polyphic hepatic injury
D. based on the assessment of stehen alkaline phosphatar and alanine aminotransferase in the blood.In a patient with nephrotic syndrome, an increase in the free fraction of acidic drugs should be expected and, consequently, the risk of an increase in their pharmacodynamic effects
E. Patients with advanced cirrhosis, treated with beta-blockers and calcium channel blockers administered per as, require increasing the doses of these drugs due to the expected reduction in their bioavailability with this route of administration
B. Formats CKD-EPI and Childe-Pugh scale allow estimation of creatinine clearance and constant rate of drug elimination in patients with acute kidney injury
C. The RUCAM classification and the R-value are used to assess polyphic hepatic injury
A positive (beneficial) drug interaction used in practice is combined use (NOTE: MULTIPLE-CHOICE)
A. Metamizole and musculotropic spasmolytic in patients with symptoms of kidney or gallstone disease
B. Ibuprofen and aspirin, which increases the anti-aggregating effect in patients with coronary atherosclerosis
C. Digoxin and rifampicin in a patient with chronic heart failure coexisting with extrapulmonary tuberculosis, which increases the concentration of both drugs in the blood and allows to shorten the treatment time
D. Paroxetine and preparations containing St. John’s wort extracts, which enhances the antidepressant effect and promotes consolidation the timoleptic effect of
E. Ketoprofen administered orally and diclofenac applied externally in the form of a gel in a patient with symptoms of osteoarthritis
A. Metamizole and musculotropic spasmolytic in patients with symptoms of kidney or gallstone disease
E. Ketoprofen administered orally and diclofenac applied externally in the form of a gel in a patient with symptoms of osteoarthritis
The patient with endoscopically diagnosed oesophageal candidiasis was started on oral itraconazole in a dose of 100 mg once daily for 4 weeks.
The control esophagoscopy revealed more intense and disseminated fungal lesions compared to the previous image, therefore the daily dose of the drug was increased to 200 mg p.o. for the next 4 weeks. The patient also developed a prolonged attack of migraine while on treatment, which prompted him to take 1.5 ml of dihydroergotamine 3 times a day (a total of 9 mg of dihydroergotamine methylsulfonate). On the next day, the patient experienced nausea and vomiting, paresthesia of peripheral parts of the body, weakness of the limbs, disorientation, arrhythmias, manifestation of side effects of the dihydroergonotamine used. What could have been their cause? (Note: Multiple Choice):
A The occurrence of a pharmacokinetic interaction during the metabolism of both drugs
B Effect of itraconazole on the increase in the volume of distribution of dihydroergotamine resulting in an increase in its concentration in the blood
C. The occurrence of a pharmacodynamic interaction in the form of competitive antagonism of both drugs with respect to effects on vascular alpha and adrenergic receptors
D something with CYP3A4
E are both not readable
B Effect of itraconazole on the increase in the volume of distribution of dihydroergotamine resulting in an increase in its concentration in the blood
D something with CYP3A4
Please indicate the statement that is false about non-commercial clinical trials:
A. A non-commercial trial may change its qualification to a commercial one upon the request of the sponsor and a positive opinion of the Bioethics Committee and the approval of the President of URPL
B. The sponsor may be supported by the responsible entity by e.g. transferring the investigational medicinal product free of charge or at a reduced cost
C. Data may be used to obtain marketing authorisation for the medicinal product
D. Participant enrolment is subject to the participant’s written consent to inform the National Health Fund of their pesel number
E. Academic research differs in purpose from commercial research
C. Data may be used to obtain marketing authorisation for the medicinal product
Patient AW takes digoxine 250 mcg since 5 years … was within the therapeutic range. … find out about the symptoms of colds in the pharmacy bought ibuprofen. After a few days of use …
What could have been the cause of the described ailments of the patient?
A. The described complication is due to allergic reaction to ibuprofen
B. The described complication is due to allergic reaction to digoxin
C. Patient … unexplained eye disease
D. Digoxin was increased due to interaction with ibuprofen
E. Neither answer is correct
D. Digoxin was increased due to interaction with ibuprofen
Patient KP is a mother who breastfeeds her 3-month-old baby. K.P. suffers from postpartum depression.
Her doctor advised her to use Fluoxetine at a dose of 20 mg a day. Can Fluoxetine be used while breastfeeding?
A. Yes, because it can also be used by pregnant women
B. No, as fluoxetine is metabolized to an active metabolite with a long biological half-life
C. No, because Fluoxetine has a high biological half-life
D. Correct answers are B, C
D. Correct answers are B, C
A Patient of the university of Warsaw is after a kidney transplant. He uses cyclosporine as a immunosuppressive therapy. One day he felt bad. The doctor diagnosed bronchitis and prescribed him clarithromycine 500g twice a day and flucanzole 50mg once a day. After 3 days of treatment the patient developed symptoms that may indicate deterioration of kidney function. What could be the cause of the symptoms?
A. Acute Transplant rejection
B. Interaction between clarithromycine and cyclosporines, resulting in a decrease in cyclosporine levels
C. interaction between clarithromycine and cyclosporine, resulting in increased levels of cyclosporine
D interaction between clarithromycine and fluconazole, resulting in increased levels of antibiotic
E. C&D are correct
E. C&D are correct